SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-052340
Filing Date
2018-09-26
Accepted
2018-09-26 18:18:54
Documents
2
Period of Report
2018-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2175
2 POA DOCUMENT poa.txt EX-24.3_810885 3782
  Complete submission text file 0001209191-18-052340.txt   7323
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA INC (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEW LEAF VENTURE PARTNERS 1200 PARK PLACE, SUITE 300 SAN MATEO CA 94043
Business Address
Dybbs Michael (Reporting) CIK: 0001601264 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38662 | Film No.: 181089017